Kerala HC Seeks Response on Breast Cancer Patient's Plea for Affordable Drug

A breast cancer patient filed a writ petition before the Kerala High Court in 2022, challenging the high cost and limited accessibility of Ribociclib, a patented drug prescribed for her condition. The petitioner argued that the drug's patent status made it prohibitively expensive and unavailable at an affordable price. The case has seen 57 hearings over the course of its proceedings. The court has now sought a formal reply in the matter, highlighting ongoing concerns about access to affordable cancer medication in India.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in